Bluejay Diagnostics, Inc. Common Stock
Follow $BJDX
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $BJDX by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredsnapshot unavailable for BJDX. Cause unavailable.
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is BJDX moving today?
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
BJDX overview
Related filings and maps
Congress activity in BJDX
Congress disclosures unavailable.
BJDX contract awards, year to date.
Public federal awards linked to this ticker.
BJDX lobbying filings, year to date.
Registered lobbying filings matched to Bluejay Diagnostics, Inc. Common Stock.